(under construction) in the Oasis of Modon in Qassim industrial region. The plant is approximately 10,000 square meters, having Oral Solid & Semi-solid facilities, and MMF (Modular Mobile Facility) for sterile injectables, with total annual capacity ~300 million Units.
Provide integrated healthcare solutions & services that significantly cover the full pharmaceutical value chain starting from R&D and registration stages to marketing and distribution.
To be one of the most reputable & reliable National Saudi manufacturers who offers high quality pharmaceutical products, and to be a partner of choice and one-stop-shop for localization of technology know-how that meet and support the Kingdom 2030 vision.
We work with the highest quality standard to build reputation in the Saudi market among patients, customers, partners & shareholders.
We harness our expertise and deep knowledge in the field of the pharmaceutical sector in Saudi Arabia that distinguish us to achieve the desired goals with distinction.
We are committed to fulfilling the requirements of the customers and partners in accordance with the specifications and the agreed period of time, and we continue to review the latest local regulations from the competent authorities.
We are open to various solutions and ideas that meet the aspirations of our customers and partners through the services we provide to them at all stages, and we positively respond to the market dynamics
We build trust with partners because we do believe it is the key to the success and continuation of fruitful long-term partnership.
Our pipeline includes well selected synergized (70) products, the company relies on both the R&D capabilities through partnering with an expert Jordanian R&D company, and the licensing through signing LSA with EU & Indian. Kinnova shall have (+10) Products submission to the SFDA in 2024.
